Corcept Therapeutics (NASDAQ:CORT – Free Report) had its target price lifted by Piper Sandler from $128.00 to $131.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an ...
Wall Street on Friday suffered its biggest weekly retreat since the peak of the COVID-19 pandemic collapse in 2020. The panic ...
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was upgraded by equities researchers at StockNews.com to a “sell” rating in a research report issued on Friday. Other equities research analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback